Clinical trial
Effect of Exenatide on Disease Progression in Early Parkinson's Disease
NCT04305002 is registered in ClinicalTrials.gov with Center for Neurology, Stockholm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Exenatide on Disease Progression in Early Parkinson's Disease
- Lead sponsor
- Center for Neurology, Stockholm
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 21, 2020
- Completion date
- October 10, 2023
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.